Trading Signals: MRK Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Merck)
| MRK latest price $60.0684 (-0.17%) ($59.8047 - $60.3133) on Sat. May. 20, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.63% (three month average) | RSI | 62 | Latest Price | $60.0684(-0.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | MRK advances 0.1% a day on average for past five trading days. | Weekly Trend | MRK advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support MRK advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting MRK price | MRK will decline at least -0.315% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.315% (StdDev 0.63%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $59.89(0.3%) | 10 Day Moving Average | $60.01(0.1%) | 20 Day Moving Average | $59.61(0.77%) | To recent high | -3.5% | To recent low | 3.1% | Market Cap | $N/A | | | | Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ. |